A look at the results ophthalmic researchers and companies are generating as they explore genetic therapies for these difficult-to-treat conditions.
The age of the patient is one of the many factors to consider when treating patients with narrow angles, experts say.
Catching up on the status of four eye drops being developed to target the disease.
Many surgeons say they’ve had a positive experience—but proceeding with caution is advised.
Review of Ophthalmology Online eNewsletter
- Prediction of Central VF Severity in Glaucoma
Find out the effectiveness of this strategy.
Predicting Treatment Frequency of Ranibizumab Injections in DMEFind out the three main contributing factors.
- Disparities in VA Outcomes after Endothelial Keratoplasty
Read about factors associated with worse VA outcomes after the procedure for Fuchs’ endothelial corneal dystrophy and bullous keratopathy.
- Progression of Atrophy Between Neovascular & Non-Neovascular AMD
Researchers are learning more about macular neovascularization’s relationship to atrophy.
- Industry News
Continuing Medical Education
In this CME Monograph from MedEdicus, a panel of expert ophthalmologists will review the common causes of ptosis and traditional therapies for ptosis correction. The panel will also review the clinical data for oxymetazoline 0.1%, a new topical medical therapy approved for ptosis treatment. In addition, a series of cases will be discussed to demonstrate the systematic evaluation of patients with ptosis and the development of individualized treatment plans.